Health News Releases

October 10, 11:10

TCG Crossover (“TCGX”) Announces Oversubscribed $1.3B TCGX Fund III

TCG Crossover (“TCGX”) today announced the successful closing of its third fund, TCGX Fund III, with $1.3 billion in capital commitments. Fund III attracted support from both current TCGX investors an

October 05, 11:55

Sobi Selects Kinaxis to Accelerate Access to Life-Changing Treatments

Kinaxis® (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.kinaxis.com%2Fen&esheet=54333058&newsitemid=20251002088321&lan=en-US&anchor=Kinaxis%26%23174%3B&index=1&md5=bc238f272987

October 05, 11:40

Neuraptive Therapeutics, Inc. Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating the Safety and Efficacy of NTX-001 Compared to Standard of Care in the Treatment of Upper Extremity Transected Nerves Requiring Surgical Repair

Neuraptive Therapeutics, Inc., a biotechnology company focused on developing novel therapies to improve outcomes in peripheral nerve injuries (PNI), today announced the first patient has been enrolled

October 02, 14:50

WHOOP Launches Clinician-Reviewed Advanced Labs, Unlocking a Comprehensive View of Human Health

WHOOP (https://www.whoop.com/kr/en/), the human performance company, today announced the launch of WHOOP Advanced Labs (https://www.whoop.com/kr/en/advanced-labs/), a groundbreaking new feature that c

October 02, 14:50

Dentalis Earns 5 VOHC® Seals, Positioning for Global Expansion in Animal Health

Dentalis Animal Health Inc. is proud to announce a landmark achievement in veterinary dentistry: the company has been awarded five prestigious Veterinary Oral Health Council (VOHC®) Seals of Approval,

October 02, 11:10

Parse Biosciences Expands Global Access by Certifying Single Cell Discoveries as a Service Provider

Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=54330033&newsitemid=20250930263922&lan=en-US&anchor=Parse+Biosciences&index=1&md5

October 01, 15:35

Microplastics in the Air: Global Study Uncovers Concerning Levels of Daily Exposure

The PlasticDustCloud project, a global study led by the Eurofins Environment Testing network, has revealed alarming microplastic pollution in air, with deposition rates of up to 1,300 microplastics pe

September 24, 16:10

AMWC Dubai: Galderma Demonstrates Injectable Aesthetics Leadership Through Updates on Its Scientific Innovations and Community Education

Galderma will present six posters with the latest updates from its science-backed aesthetic portfolio at the Aesthetic & Anti-Aging Medicine World Congress (AMWC) in Dubai, United Arab Emirates, from

September 24, 15:30

Variational AI Enters Collaboration with Merck to Apply Generative AI to Drug Discovery

Variational AI, Inc., a generative AI drug discovery company, today announced a collaboration with Merck, known as MSD outside of the United States and Canada, to apply Variational AI’s Enki™ platform

September 24, 09:32

20,000 + Takeda Employees Voted to Select Four New Global Corporate Social Responsibility Collaborations to Advance Climate-Resilient Health Systems in 94 Countries

Takeda (TOKYO:4502/NYSE: TAK) today committed JPY 4.6 billion (approx. USD 32.1 million) to four new Global Corporate Social Responsibility (CSR) partners as part of the company’s ongoing commitment t

September 18, 14:40

Rubedo Life Sciences Announces U.S. FDA Clearance of IND for Selective GPX4 Modulating Lead Drug Candidate RLS-1496 for Actinic Keratosis, Expands Clinical Advisory Board

Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on discovering and rapidly developing selective cellular rejuvenation medicines targeting aging cells, today announced

September 18, 14:25

New Study Finds That Using Masimo Technologies to Continuously Monitor General Floor Patients Reduces Costs

Masimo (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.masimo.com&esheet=54324636&newsitemid=20250917266545&lan=en-US&anchor=Masimo&index=1&md5=1c2d4fc2fd80ea476e53a7e74df69244)

September 18, 13:55

Merck to Present New Data Highlighting Durable Effects of MAVENCLAD® in Relapsing Multiple Sclerosis (RMS) at ECTRIMS 2025

Not intended for UK-, US- or Canada-based media Merck, a leading science and technology company, today announced the presentation of over 30 abstracts from its multiple sclerosis (MS) portfolio. Ne

September 17, 16:10

Galderma’s Groundbreaking Real-World Study Reveals the Biological Toll of Modern Living and Urban Environments on Sensitive Skin

Galderma today announced new data from a first-of-its-kind real-world clinical study conducted in China assessing the biological impact of different lifestyles and their associated environmental facto

September 17, 10:05

Biocytogen Announces ADC Innovator Tubulis Has Signed Global Exclusive License Agreement for Single Antibody

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technolo

September 17, 08:59

Takeda and VELA to Ship Medicines Across the Atlantic Using First-of-its-Kind Wind-Powered Trimaran

Takeda (TSE:4502/NYSE:TAK) and VELA Transport today announced their business partnership, with Takeda set to become the first biopharmaceutical company to transport its products between Europe and the

September 16, 17:35

FrieslandCampina Ingredients Expands R&D Capabilities with New State-of-the-Art Application Centre in Singapore

FrieslandCampina Ingredients, a global leader in proteins and prebiotics, has announced the opening of a new application centre in Singapore, representing a 30% increase of R&D space in the city-state

September 16, 14:00

MEDIPEAU Showcases its Film-Type Wound Dressing Cream at 51st Annual Fall Meeting of Korean Pediatric Association

MEDIPEAU Inc., a company specializing in therapeutic solutions for atopic dermatitis, introduced its groundbreaking “BARRICURE Aid Film MD” during the 51st Annual Fall Meeting of the Korean Pediatric

September 16, 09:45

Helmholtz Munich and Parse Biosciences GigaLab Generate World’s Largest Human Lung Tissue Perturbation Atlas

Helmholtz Munich and Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=54323217&newsitemid=20250915189668&lan=en-US&anchor=Parse+Bi

September 12, 16:20

Medicines Discovery Catapult and Crown Bioscience Form Strategic Global Alliance for Radiopharmaceutical Innovation

Medicines Discovery Catapult (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fmd.catapult.org.uk%2F&esheet=54321838&newsitemid=20250911458780&lan=en-US&anchor=Medicines+Discovery+Cat

September 12, 15:20

Ferring Japan announces PMDA Acceptance of NDA Filing for nadofaragene firadenovec

Ferring Pharmaceuticals Co., Ltd. announced that the PMDA has accepted the NDA for nadofaragene firadenovec for review, following submission on August 27th, 2025. This non-replicating gene therapy, ad

September 12, 13:35

Nominations Open for Fifth Edition of Aster Guardians Global Nursing Award 2026 Worth USD 250,000

Aster DM Healthcare has announced the launch of the fifth edition of the Aster Guardians Global Nursing Award, one of the world’s most prominent recognition for nursing excellence worth USD 250,000.

September 12, 10:55

Promega and Watchmaker Genomics Announce Strategic Partnership to Advance Molecular Analysis with Next-Generation Reverse Transcriptase

Promega Corporation (https://www.promega.kr/?utm_source=businesswire.com&utm_medium=referral&utm_campaign=%28referral%29) has entered a strategic partnership with Watchmaker Genomics (https://www.watc

September 11, 15:50

EADV 2025: Galderma Reinforces Leadership in Dermatology With Latest Advances in Sensitive Skin and Itch

Galderma (SIX: GALD), the dermatology category leader, today announced it will unveil updates from its portfolio at the 34th European Academy of Dermatology and Venereology (EADV) congress, taking pla

September 10, 16:30

Galderma Launches Alastin® in China, Supporting the Skin’s Natural Regenerative Abilities in a Rapidly Expanding Market

Galderma (SIX: GALD) today announced the launch of four core Alastin® products in China, marking the premium medical skincare brand’s debut in one of the world’s fastest growing aesthetic skincare mar

News by Region

News by Industry